Cenicriviroc

Generic Name: Cenicriviroc

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₄₁H_₅₂N_₄O_₄S

CAS Number: 497223-25-3

Unique Ingredient Identifier: 15C116UA4Y

Background: Cenicriviroc has been used in trials studying the treatment of HIV-infection/AIDS, AIDS Dementia Complex, Nonalcoholic Steatohepatitis, Human Immunodeficiency Virus, and HIV-1-Associated Cognitive Motor Complex.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

Phase 2

Withdrawn

Conditions: HIV Infections

Interventions: Drug: Cenicriviroc Mesylate (CVC)
Drug: Placebo

First Posted Date: 2020-04-06

Last Posted Date: 2022-12-21

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT04334915

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy